Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
about
TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer modelA gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykDiversity of matriptase expression level and function in breast cancer.Role of emmprin in endometrial cancerLoss of function of e-cadherin in embryonic stem cells and the relevance to models of tumorigenesisEndogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation.Hepatic stellate cells secretes type I collagen to trigger epithelial mesenchymal transition of hepatoma cells.Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transitionSj7170, a unique dual-function peptide with a specific α-chymotrypsin inhibitory activity and a potent tumor-activating effect from scorpion venom.TMPRSS4-dependent activation of the epithelial sodium channel requires cleavage of the γ-subunit distal to the furin cleavage siteMatriptase promotes inflammatory cell accumulation and progression of established epidermal tumors.Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesisZEB1-responsive genes in non-small cell lung cancerMembrane-anchored serine proteases in health and disease.Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5.Epithelial-mesenchymal transition in pancreatic carcinomaMechanisms of hepatocyte growth factor activation in cancer tissues.Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer.Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation modelIncreased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2.Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells.The cellular character of liquefaction degeneration in oral lichen planus and the role of interferon gamma.Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma.Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.Recombinant hepatocyte growth factor activator inhibitor 1: expression in Drosophila S2 cells, purification and crystallization.Expression of matriptase correlates with tumour progression and clinical prognosis in oral squamous cell carcinoma.Clinical implication of TMPRSS4 expression in human gallbladder cancer.The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells.Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer
P2860
Q28478908-E8A2D178-E597-4553-B89B-138CE4776159Q30496002-1D710C3D-CF3F-46AE-BB2C-609675BE3502Q34238503-EC38E520-31C3-4DBD-A6AD-58450A2A65ACQ34284285-974460BA-1D6A-4CFF-A30E-D703DF3E1AEEQ34423998-AC2D87CE-B41C-4824-9C8F-AFC41B93C5A2Q34568589-5BE85419-AEEE-4147-8C9E-5DDE4444C214Q34704882-E951ECE6-9871-4D54-A103-C423B04BAE6BQ34984574-FA1F23B4-F5ED-4DD6-B04F-BDC8CA2591ABQ35105421-95721D38-19C7-4BD2-AD46-D73DF6A7AA83Q35652104-B7660244-7546-4894-A8EF-668FCADD93BDQ35696184-29C64061-2DBF-412B-9523-A20E620CA503Q35810625-39CCD091-57CF-4A31-9D22-04974AAC4747Q35823094-1F7E316D-3440-4340-B17F-6E06DAABAFFEQ35915752-252DB7FE-49BE-491E-A9F6-0E59579F63B4Q36969010-983F675C-F69D-4317-BB7F-478A4C22733BQ37164922-B3248304-0E1F-411B-9D5B-EF2A4557484EQ37357076-04B95D21-3158-44B3-AB9E-DD16EFCEB08FQ37709042-55425F73-E536-4AA5-A6B6-6D47F40BE637Q38166588-C6B2A8CC-0516-4AC2-9339-7B0188E6481CQ38255480-B3AB26AB-D48C-4C3C-B070-151130C8D06AQ38575459-DACA0091-414F-4E92-BF59-6CFD84CA30C6Q38670573-80451799-48A7-4DD3-8725-2CB1D007E436Q38771773-84359F9B-C225-49C7-8B10-F2E3B07517B3Q39074016-5A3A11B9-13ED-4134-9684-B462D577784DQ39177327-C9B8F753-054D-460F-92F0-C67C570F664BQ39409341-30A1931D-E45E-465B-8846-E57654CF8D2BQ39437208-761D4F84-8D47-4210-B2FA-75F5F9449121Q39618840-A031EDF8-48F2-4651-AD4F-6C20B04906A3Q42510397-E1967935-B614-4E8C-9166-CF3A8B9563F5Q47133508-7FA75DDE-E1B3-4DB8-861F-A92ACCD41CA8Q47157413-1A26A0EB-7F33-4F82-AF70-41AB3F4EA280Q47632003-45817EC7-CB73-4078-82AA-647F4AFC54F8Q51221442-6A9EF499-5C6E-4475-BCB9-726B52D6A030Q53075335-455021C3-9281-4B70-ADB0-BF8738095AC2Q54222481-9E9E7237-DC12-4FC6-BB0B-0601A4F0BF90Q54415251-9E6F4CA8-8A03-4828-9BFF-9066DA28ACE4Q55343941-1C247FA5-33B9-43AD-BF65-993BB420EAC9Q57484740-F07807EE-1967-4E94-AE4A-7099C803CC3E
P2860
Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Hepatocyte growth factor activ ...... rane-bound serine proteinases.
@en
Hepatocyte growth factor activ ...... rane-bound serine proteinases.
@nl
type
label
Hepatocyte growth factor activ ...... rane-bound serine proteinases.
@en
Hepatocyte growth factor activ ...... rane-bound serine proteinases.
@nl
prefLabel
Hepatocyte growth factor activ ...... rane-bound serine proteinases.
@en
Hepatocyte growth factor activ ...... rane-bound serine proteinases.
@nl
P2093
P1433
P1476
Hepatocyte growth factor activ ...... rane-bound serine proteinases.
@en
P2093
Haixia Cheng
Hiroaki Kataoka
Hiroyuki Tanaka
Nobuyasu Takahashi
Tsuyoshi Fukushima
P304
P356
10.1158/0008-5472.CAN-08-3728
P407
P577
2009-02-17T00:00:00Z